Yujie Tang
Affiliations: | Shanghai Jiao Tong University School of Medicine |
Google:
"Yujie Tang"Mean distance: (not calculated yet)
Parents
Sign in to add mentor
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Sui Y, Wang T, Mei Y, et al. (2024) Targeting Super-Enhancer-Driven Transcriptional Dependencies Suppresses Aberrant Hedgehog Pathway Activation and Overcomes Smoothened Inhibitor Resistance. Cancer Research |
| Mo J, Tan K, Dong Y, et al. (2022) Therapeutic targeting the oncogenic driver EWSR1::FLI1 in Ewing sarcoma through inhibition of the FACT complex. Oncogene |
| Mo J, Liu F, Sun X, et al. (2021) Inhibition of the FACT complex targets aberrant hedgehog signaling and overcomes resistance to smoothened antagonists. Cancer Research |
| Ehteda A, Simon S, Franshaw L, et al. (2021) Dual targeting of the epigenome via FACT complex and histone deacetylase is a potent treatment strategy for DIPG. Cell Reports. 35: 108994 |
| Liu F, Jiang W, Sui Y, et al. (2019) CDK7 inhibition suppresses aberrant hedgehog pathway and overcomes resistance to smoothened antagonists. Proceedings of the National Academy of Sciences of the United States of America |
| Lu P, Geng J, Zhang L, et al. (2019) THZ1 reveals CDK7-dependent transcriptional addictions in pancreatic cancer. Oncogene |
| Zhang L, Li M, Hou L, et al. (2019) MEDU-06. TARGETING MYC AND OTX2-DRIVEN TRANSCRIPTIONAL DEPENDENCIES OF GROUP 3 MEDULLOBLASTOMA THROUGH CDK7 INHIBITION Neuro-Oncology. 21: ii104-ii104 |
| Meng W, Wang J, Wang B, et al. (2018) CDK7 inhibition is a novel therapeutic strategy against GBM both in vitro and in vivo. Cancer Management and Research. 10: 5747-5758 |
| Liu X, Bao Y, Meng W, et al. (2018) TROY interacts with RKIP to promote glioma development. Oncogene |
| Meng W, Wang B, Mao W, et al. (2018) Enhanced efficacy of histone deacetylase inhibitor combined with bromodomain inhibitor in glioblastoma. Journal of Experimental & Clinical Cancer Research : Cr. 37: 241 |